Search for: "Solvay Pharmaceuticals Inc" Results 21 - 40 of 50
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Mar 2013, 12:49 pm by John J. Sullivan
Mar. 5, 2013), the plaintiffs were qui tam relators who’d sparked investigations by state AGs into alleged False Claims Act violations by the pharmaceutical manufacturer, Abbot Products, Inc., which was later acquired by Solvay Pharmaceuticals, Inc.. [read post]
12 Jul 2012, 7:57 am by mstein03
(“Solvay”), agreed to make over $20 million annual payments to the generic challengers Watson Pharmaceuticals, Inc., Par Pharmaceuticals, Inc., and Paddock Laboratories, Inc. [read post]
25 Apr 2010, 5:52 pm by FDABlog HPM
II) – This case stems from a February 2009 challenge by the FTC and the California Attorney General concerning  Solvay Pharmaceuticals, Inc. [read post]
17 Jun 2013, 1:21 pm by Lyle Denniston
  The initial patent had run out, but the U.S. licensee — Solvay Pharmaceuticals, Inc. [read post]
5 Aug 2009, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: America’s Affordable Health Choices Act : House Energy & Commerce Committee OKs 12-year data exclusivity for biotech drugs (Patent Baristas) (Patent Docs) (FDA Law Blog) (PatentlyBIOtech) (GenericsWeb)   General Pharmaceutical patent settlements under fire on both sides of the Atlantic (GenericsWeb)… [read post]
1 Mar 2014, 6:22 am by Legal Reader
Before the drug was approved by the FDA in 2000, Solvay Pharmaceuticals Inc. acquired Unimed Pharmaceuticals, Inc. and subsequently brought AndroGel to market. [read post]
2 Jun 2011, 12:46 pm by Bexis
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
10 Jun 2010, 10:41 am by FDABlog HPM
  As we previously reported, in that case the district court largely dismissed multidistrict litigation brought by the FTC, direct purchasers, and indirect purchasers challenging certain agreements in which Solvay Pharmaceuticals, Inc. allegedly paid generic drug companies to delay generic competition to Solvay’s drug product ANDROGEL (testosterone gel). [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
28 Sep 2009, 1:31 am
Solvay America, Inc., 212 P.3d 614, 632 (Wyo. 2009); Lovick v. [read post]